zhengping hu
Schepens Eye Research Institute, Harvard Medical School
Boston, United States
Review Editor
Molecular and Cellular Pathology
Schepens Eye Research Institute, Harvard Medical School
Boston, United States
Review Editor
Molecular and Cellular Pathology
The Rockefeller University
New York City, United States
Review Editor
Molecular and Cellular Pathology
Tulane Cancer Center, School of Medicine, Tulane University
New Orleans, United States
Review Editor
Molecular and Cellular Pathology
West China School of Medicine, West China Hospital, Sichuan University
Chengdu, China
Review Editor
Molecular and Cellular Pathology
Precision Therapeutics (United States)
Pittsburgh, United States
Review Editor
Molecular and Cellular Pathology
Yale University
New Haven, United States
Review Editor
Molecular and Cellular Pathology
West China School of Medicine, West China Hospital, Sichuan University
Chengdu, China
Review Editor
Molecular and Cellular Pathology
Trent University
Peterborough, Canada
Review Editor
Molecular and Cellular Pathology
Rosalind Franklin University of Medicine and Science
North Chicago, United States
Review Editor
Molecular and Cellular Pathology
National Cancer Institute (NIH)
Rockville, United States
Review Editor
Molecular and Cellular Pathology
Faculty of Medicine, University of Seville
Seville, Spain
Review Editor
Molecular and Cellular Pathology
Kyoto University
Kyoto, Japan
Review Editor
Molecular and Cellular Pathology
Gyeongsang National University
Jinju, Republic of Korea
Review Editor
Molecular and Cellular Pathology
The University of Texas Health Science Center at San Antonio
San Antonio, United States
Review Editor
Molecular and Cellular Pathology
School of Medicine, Indiana University Bloomington
Indianapolis, United States
Review Editor
Molecular and Cellular Pathology
Institute of Applied Sciences and Intelligent Systems, Department of Physical Sciences and Technologies of Matter, National Research Council (CNR)
Pozzuoli, Italy
Review Editor
Molecular and Cellular Pathology